Focus Reports
Dermatological Drugs: United States
This report forecasts US demand in 2021 for prescription dermatological drugs by product in nominal US dollars at the manufacturers' level.
Free Sample Report
Request a free sample of this report and our team will email it to you.
Report Overview
Dermatological Drugs: United StatesThis report forecasts US demand in 2021 for prescription dermatological drugs by product in nominal US dollars at the manufacturers' level. Product segments include antiaging and photodamage drugs, psoriasis drugs, antifungal drugs, skin cancer drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, hair loss and hair removal drugs, hyperpigmentation/melasma and depigmenting drugs, and other products.
To illustrate historical trends, total demand and the various segments are provided for 2016.
- Highlights
- Market Environment
- Introduction
- Dermatological Conditions & Treatment
- Table | Common Bases for Topical Dermatological Medications
- Regulatory Factors
- Segmentation & Forecasts
- Products
- Figure 1 | US Dermatological Drug Demand by Product; 2016, 2021
- Table | US Dermatological Drug Demand by Product; 2016, 2021
- Antiaging & Photodamage Drugs
- Psoriasis Drugs
- Antifungal Drugs
- Skin Cancer Drugs
- Acne & Rosacea Drugs
- Dermatitis & Seborrhea Drugs
- Hair Loss & Hair Removal Drugs
- Hyperpigmentation/Melasma & Depigmenting Drugs
- Other Skin Disorder Drugs
- Figure 2 | US Dermatological Drug Demand by Product; 2016, 2021
- Products
- Industry Structure
- Industry Characteristics
- Market Leaders
- Table | Select Suppliers to the US Dermatological Drug Market
- Allergan
- Merck & Company
- Novartis Pharmaceuticals Corporation
- About This Report
- Scope & Method
- Sources
- Industry Codes
- Table | Industry Codes Related to Dermatological Drugs
- Resources
